CA2670362A1 — Compounds modulating c-fms and/or c-kit activity and uses therefor
Assigned to Daiichi Sankyo Inc · Expires 2008-05-29 · 18y expired
What this patent protects
Compounds active on the receptor protein tyrosine kinases c-kit and/or c- fms are provided herewith. Also provided herewith are compositions useful fo r treatment of c-kit mediated diseases or conditions and/or c-fms-mediated d iseases or conditions, and methods for the use there…
USPTO Abstract
Compounds active on the receptor protein tyrosine kinases c-kit and/or c- fms are provided herewith. Also provided herewith are compositions useful fo r treatment of c-kit mediated diseases or conditions and/or c-fms-mediated d iseases or conditions, and methods for the use thereof.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.